ZCL-278 is a small-molecule inhibitor that selectively targets Cdc42, a Rho GTPase involved in cytoskeletal organization and cell signaling. It disrupts Cdc42 interactions with its guanine nucleotide exchange factors (GEFs), affecting cell migration and actin dynamics. ZCL-278 has been studied for its potential in cancer and neurobiology research.
MedKoo Cat#: 531341
Name: ZCL-278
CAS#: 587841-73-4
Chemical Formula: C21H19BrClN5O4S2
Exact Mass: 582.9750
Molecular Weight: 584.89
Elemental Analysis: C, 43.12; H, 3.27; Br, 13.66; Cl, 6.06; N, 11.97; O, 10.94; S, 10.96
The following data is based on the product molecular weight 584.89 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
